Ownership and insider activity for Profound Medical Corp. (PROF): insider transactions, US Senate and House trading disclosures and shares outstanding. Track how corporate insiders and politicians are trading the stock.
Profound Medical Corp., through its subsidiaries, is a commercial-stage medical technology firm specializing in the development of magnetic resonance (MR)-guided ablation solutions. These innovative procedures are designed to treat conditions such as prostate disease and uterine fibroids, as well as providing palliative pain relief. The company markets its solutions across Canada, Germany, the United States, and Finland.
Price
| Price | $5.89 |
| Market Cap | $214M |
| Exchange | NASDAQ |
| Country | CA |
Balance Sheet (10y)
| Year | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $15.5M | $8.8M | $22.5M | $14.8M | $83.9M | $67.1M | $46.5M | $26.2M | $54.9M | $81.8M |
| Short-term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | $265946 | $3.6M | $1.5M | $3.3M | $7.4M | $1.4M | $6.3M | $7.3M | $7.0M | $9.9M |
| Inventory | $310113 | $1.1M | $3.6M | $3.7M | $5.3M | $7.4M | $7.9M | $7.0M | $5.8M | $11.3M |
| Total Current Assets | $16.7M | $14.0M | $37.9M | $22.8M | $97.7M | $77.0M | $62.0M | $41.9M | $69.1M | $104.2M |
| Property, Plant & Equipment | $709046 | $1.4M | $886439 | $2.2M | $2.3M | $1.9M | $1.7M | $1.6M | $821010 | $225000 |
| Goodwill | 0 | $2.7M | $2.5M | $2.6M | $2.7M | $2.7M | 0 | 0 | 0 | 0 |
| Intangible Assets | $195435 | $4.1M | $2.9M | $2.4M | $1.9M | $1.4M | $680000 | $490000 | $261000 | $138000 |
| Total Assets | $17.6M | $22.2M | $46.4M | $30.1M | $104.6M | $86.7M | $64.4M | $44.0M | $70.2M | $192.9M |
| Accounts Payable | $1.3M | $4.0M | $2.9M | $3.0M | $3.4M | $3.2M | $2.0M | $865000 | $1.3M | $2.1M |
| Short-term Debt | $2.9M | $4.8M | $983519 | $4.2M | $312000 | $249661 | $523000 | $2.1M | $1.7M | $291731 |
| Total Current Liabilities | $3.7M | $8.5M | $5.8M | $8.2M | $4.8M | $4.1M | $4.2M | $6.4M | $6.6M | $8.3M |
| Long-term Debt | $3.8M | $352982 | $10.6M | $5.2M | 0 | 0 | $6.7M | $5.0M | $2.9M | $6.2M |
| Total Liabilities | $6.6M | $10.9M | $14.6M | $15.7M | $7.3M | $6.1M | $12.4M | $12.7M | $9.8M | $102.0M |
| Retained Earnings | -$53.2M | -$71.8M | -$111.0M | -$101.1M | -$130.0M | -$160.5M | -$189.4M | -$217.4M | -$245.2M | -$394.1M |
| Total Equity | $11.0M | $11.2M | $26.6M | $14.4M | $97.3M | $80.5M | $52.0M | $31.2M | $60.4M | $91.0M |
| Total Debt | $4.9M | $4.1M | $8.8M | $11.0M | $1.7M | $1.4M | $8.2M | $7.9M | $5.1M | $6.5M |
| Net Debt | -$10.6M | -$4.7M | -$21.9M | -$3.8M | -$82.2M | -$65.7M | -$38.3M | -$18.3M | -$49.8M | -$75.3M |
| Working Capital | $13.0M | $5.5M | $32.1M | $14.6M | $92.9M | $72.9M | $57.8M | $35.5M | $62.5M | $95.9M |
Financial Health
| Debt / Equity | 0.15 |
| Current Ratio | 6.46 |
Profitability
| Return on Equity | -62.45% |
| Return on Invested Capital | -60.49% |
| Return on Assets | -52.05% |
| Gross Margin | 71.73% |
| Operating Margin | -184.35% |
| Net Margin | -170.92% |
Related companies: ARMP · AVR · CATX · LNSR · MXCT · NNOX · OWLT
Explore sector: Healthcare · Medical - Devices
More sections of PROF: Overview · Financials · Valuation · Statistics · Estimates · Technical · News · Events
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks